G K Dy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

G K Dy

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

European Journal of Cancer (Oxford, England : 1990)|August 15, 2002

Farnesyl transferase inhibitors as anticancer agentsP Haluska, G K Dy, A A Adjei

Expert Opinion on Investigational Drugs|January 5, 2002

Novel pharmacological agents in clinical development for solid tumoursG K Dy, P Haluska, A A Adjei

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG studyG K Dy, A A Miller, S J Mandrekar, et al.

Cancer Chemotherapy and Pharmacology|February 26, 2013

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancerN Ramnath, S Daignault-Newton, G K Dy, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

European Journal of Cancer (Oxford, England : 1990)|August 15, 2002

Farnesyl transferase inhibitors as anticancer agentsP Haluska, G K Dy, A A Adjei

Expert Opinion on Investigational Drugs|January 5, 2002

Novel pharmacological agents in clinical development for solid tumoursG K Dy, P Haluska, A A Adjei

Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG studyG K Dy, A A Miller, S J Mandrekar, et al.

Cancer Chemotherapy and Pharmacology|February 26, 2013

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancerN Ramnath, S Daignault-Newton, G K Dy, et al.

Pageof 1